Report Detail

Request for Sample of this report

Chemical & Material Global Sorafenib Tosylate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4534300
    • |
  • 09 June, 2023
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Sorafenib Tosylate API market size was valued at USD 36 million in 2022 and is forecast to a readjusted size of USD 53 million by 2029 with a CAGR of 5.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Sorafenib Tosylate is an active pharmaceutical ingredient (API) that is used in the treatment of certain types of cancer, including advanced renal cell carcinoma and hepatocellular carcinoma. It works by blocking the action of enzymes and proteins that are involved in cancer cell growth and division.
This report is a detailed and comprehensive analysis for global Sorafenib Tosylate API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Sorafenib Tosylate API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Sorafenib Tosylate API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Sorafenib Tosylate API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Sorafenib Tosylate API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sorafenib Tosylate API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sorafenib Tosylate API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva API, Natco Pharma, Cipla, Alembic Pharmaceutical and Hetero, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Sorafenib Tosylate API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
FormⅠ
Form Ⅲ
Market segment by Application
Pharmaceutical
Scientific Research
Other
Major players covered
Teva API
Natco Pharma
Cipla
Alembic Pharmaceutical
Hetero
Aurobindo Pharma
Sun Pharmaceutical Industries
BDR Lifesciences
Delmar Chemicals
Yabao Pharmaceutical Group
Sichuan Xieli Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sorafenib Tosylate API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sorafenib Tosylate API, with price, sales, revenue and global market share of Sorafenib Tosylate API from 2018 to 2023.
Chapter 3, the Sorafenib Tosylate API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sorafenib Tosylate API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Sorafenib Tosylate API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sorafenib Tosylate API.
Chapter 14 and 15, to describe Sorafenib Tosylate API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Sorafenib Tosylate API
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sorafenib Tosylate API Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 FormⅠ
    • 1.3.3 Form Ⅲ
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Sorafenib Tosylate API Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Pharmaceutical
    • 1.4.3 Scientific Research
    • 1.4.4 Other
  • 1.5 Global Sorafenib Tosylate API Market Size & Forecast
    • 1.5.1 Global Sorafenib Tosylate API Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Sorafenib Tosylate API Sales Quantity (2018-2029)
    • 1.5.3 Global Sorafenib Tosylate API Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Teva API
    • 2.1.1 Teva API Details
    • 2.1.2 Teva API Major Business
    • 2.1.3 Teva API Sorafenib Tosylate API Product and Services
    • 2.1.4 Teva API Sorafenib Tosylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Teva API Recent Developments/Updates
  • 2.2 Natco Pharma
    • 2.2.1 Natco Pharma Details
    • 2.2.2 Natco Pharma Major Business
    • 2.2.3 Natco Pharma Sorafenib Tosylate API Product and Services
    • 2.2.4 Natco Pharma Sorafenib Tosylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Natco Pharma Recent Developments/Updates
  • 2.3 Cipla
    • 2.3.1 Cipla Details
    • 2.3.2 Cipla Major Business
    • 2.3.3 Cipla Sorafenib Tosylate API Product and Services
    • 2.3.4 Cipla Sorafenib Tosylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Cipla Recent Developments/Updates
  • 2.4 Alembic Pharmaceutical
    • 2.4.1 Alembic Pharmaceutical Details
    • 2.4.2 Alembic Pharmaceutical Major Business
    • 2.4.3 Alembic Pharmaceutical Sorafenib Tosylate API Product and Services
    • 2.4.4 Alembic Pharmaceutical Sorafenib Tosylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Alembic Pharmaceutical Recent Developments/Updates
  • 2.5 Hetero
    • 2.5.1 Hetero Details
    • 2.5.2 Hetero Major Business
    • 2.5.3 Hetero Sorafenib Tosylate API Product and Services
    • 2.5.4 Hetero Sorafenib Tosylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Hetero Recent Developments/Updates
  • 2.6 Aurobindo Pharma
    • 2.6.1 Aurobindo Pharma Details
    • 2.6.2 Aurobindo Pharma Major Business
    • 2.6.3 Aurobindo Pharma Sorafenib Tosylate API Product and Services
    • 2.6.4 Aurobindo Pharma Sorafenib Tosylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Aurobindo Pharma Recent Developments/Updates
  • 2.7 Sun Pharmaceutical Industries
    • 2.7.1 Sun Pharmaceutical Industries Details
    • 2.7.2 Sun Pharmaceutical Industries Major Business
    • 2.7.3 Sun Pharmaceutical Industries Sorafenib Tosylate API Product and Services
    • 2.7.4 Sun Pharmaceutical Industries Sorafenib Tosylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
  • 2.8 BDR Lifesciences
    • 2.8.1 BDR Lifesciences Details
    • 2.8.2 BDR Lifesciences Major Business
    • 2.8.3 BDR Lifesciences Sorafenib Tosylate API Product and Services
    • 2.8.4 BDR Lifesciences Sorafenib Tosylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 BDR Lifesciences Recent Developments/Updates
  • 2.9 Delmar Chemicals
    • 2.9.1 Delmar Chemicals Details
    • 2.9.2 Delmar Chemicals Major Business
    • 2.9.3 Delmar Chemicals Sorafenib Tosylate API Product and Services
    • 2.9.4 Delmar Chemicals Sorafenib Tosylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Delmar Chemicals Recent Developments/Updates
  • 2.10 Yabao Pharmaceutical Group
    • 2.10.1 Yabao Pharmaceutical Group Details
    • 2.10.2 Yabao Pharmaceutical Group Major Business
    • 2.10.3 Yabao Pharmaceutical Group Sorafenib Tosylate API Product and Services
    • 2.10.4 Yabao Pharmaceutical Group Sorafenib Tosylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Yabao Pharmaceutical Group Recent Developments/Updates
  • 2.11 Sichuan Xieli Pharmaceutical
    • 2.11.1 Sichuan Xieli Pharmaceutical Details
    • 2.11.2 Sichuan Xieli Pharmaceutical Major Business
    • 2.11.3 Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Product and Services
    • 2.11.4 Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Sichuan Xieli Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Sorafenib Tosylate API by Manufacturer

  • 3.1 Global Sorafenib Tosylate API Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Sorafenib Tosylate API Revenue by Manufacturer (2018-2023)
  • 3.3 Global Sorafenib Tosylate API Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Sorafenib Tosylate API by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Sorafenib Tosylate API Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Sorafenib Tosylate API Manufacturer Market Share in 2022
  • 3.5 Sorafenib Tosylate API Market: Overall Company Footprint Analysis
    • 3.5.1 Sorafenib Tosylate API Market: Region Footprint
    • 3.5.2 Sorafenib Tosylate API Market: Company Product Type Footprint
    • 3.5.3 Sorafenib Tosylate API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sorafenib Tosylate API Market Size by Region
    • 4.1.1 Global Sorafenib Tosylate API Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Sorafenib Tosylate API Consumption Value by Region (2018-2029)
    • 4.1.3 Global Sorafenib Tosylate API Average Price by Region (2018-2029)
  • 4.2 North America Sorafenib Tosylate API Consumption Value (2018-2029)
  • 4.3 Europe Sorafenib Tosylate API Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Sorafenib Tosylate API Consumption Value (2018-2029)
  • 4.5 South America Sorafenib Tosylate API Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Sorafenib Tosylate API Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Sorafenib Tosylate API Sales Quantity by Type (2018-2029)
  • 5.2 Global Sorafenib Tosylate API Consumption Value by Type (2018-2029)
  • 5.3 Global Sorafenib Tosylate API Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Sorafenib Tosylate API Sales Quantity by Application (2018-2029)
  • 6.2 Global Sorafenib Tosylate API Consumption Value by Application (2018-2029)
  • 6.3 Global Sorafenib Tosylate API Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Sorafenib Tosylate API Sales Quantity by Type (2018-2029)
  • 7.2 North America Sorafenib Tosylate API Sales Quantity by Application (2018-2029)
  • 7.3 North America Sorafenib Tosylate API Market Size by Country
    • 7.3.1 North America Sorafenib Tosylate API Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Sorafenib Tosylate API Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Sorafenib Tosylate API Sales Quantity by Type (2018-2029)
  • 8.2 Europe Sorafenib Tosylate API Sales Quantity by Application (2018-2029)
  • 8.3 Europe Sorafenib Tosylate API Market Size by Country
    • 8.3.1 Europe Sorafenib Tosylate API Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Sorafenib Tosylate API Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sorafenib Tosylate API Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Sorafenib Tosylate API Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Sorafenib Tosylate API Market Size by Region
    • 9.3.1 Asia-Pacific Sorafenib Tosylate API Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Sorafenib Tosylate API Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Sorafenib Tosylate API Sales Quantity by Type (2018-2029)
  • 10.2 South America Sorafenib Tosylate API Sales Quantity by Application (2018-2029)
  • 10.3 South America Sorafenib Tosylate API Market Size by Country
    • 10.3.1 South America Sorafenib Tosylate API Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Sorafenib Tosylate API Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sorafenib Tosylate API Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Sorafenib Tosylate API Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Sorafenib Tosylate API Market Size by Country
    • 11.3.1 Middle East & Africa Sorafenib Tosylate API Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Sorafenib Tosylate API Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Sorafenib Tosylate API Market Drivers
  • 12.2 Sorafenib Tosylate API Market Restraints
  • 12.3 Sorafenib Tosylate API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sorafenib Tosylate API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sorafenib Tosylate API
  • 13.3 Sorafenib Tosylate API Production Process
  • 13.4 Sorafenib Tosylate API Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sorafenib Tosylate API Typical Distributors
  • 14.3 Sorafenib Tosylate API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Sorafenib Tosylate API. Industry analysis & Market Report on Sorafenib Tosylate API is a syndicated market report, published as Global Sorafenib Tosylate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Sorafenib Tosylate API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,731.80
    		4,097.70
    		5,463.60
    		3,208.56
    		4,812.84
    		6,417.12
    		546,325.20
    		819,487.80
    		1,092,650.40
    		289,222.80
    		433,834.20
    		578,445.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo